Cytokines in implantation

Seminars in Reproductive Medicine

Volumn 18, Issue 3, 2000, Pages 299-310

  Salamonsen, L A ^a   Dimitriadis, E ^a   Robb, L ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Interleukin 1; Interleukin 11; Leukemia inhibitory factor

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR;

BLASTOCYST; CYTOKINE PRODUCTION; DECIDUALIZATION; ENDOMETRIUM; GENE EXPRESSION; MOUSE; NIDATION; NONHUMAN; REVIEW; STROMA CELL;

ANTIGENS, CD; COLONY-STIMULATING FACTORS; CYTOKINE RECEPTOR GP130; CYTOKINES; EMBRYO IMPLANTATION; ENDOMETRIUM; EPITHELIUM; FEMALE; HUMANS; INTERLEUKIN-1; MEMBRANE GLYCOPROTEINS; PREGNANCY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034458869     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-12567     Document Type: Review

References (122)

1. Placentation
2. Cytokines
3. Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1 regulated placental development
4. Cytokines: Pivotal regulators of endometriai immunobiology
5. Female steroid hormones regulate production of pro-inflammatory molecules in uterine leukocytes
6. Expression of the chemokine eotaxin and its receptor CCR3 in human endometrium
7. TGF-α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
8. CSF-1: A mononuclear phagocyte lineage-specific hemopoietic growth factor
9. Regulation of colony-stimulating factor 1 during pregnancy
10. Apparent role of the macrophage growth factor CSF-1 in placental development
11. Expression of CSF-1/c-fms and SF/c-kit mRNA during preimplantation mouse development
12. Colony-stimulating factor-1 and c-fms expression in human endometrial and placenta during the menstrual cycle and early pregnancy
13. Expression of colony-stimulating factor-1 in the human uterus and placenta
14. Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion
15. Partial characterisation of an immortalised trophoblast cell-line
16. Role of colony-stimulating factor-1 in reproduction and development
17. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female infertility
18. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells
19. Uterine epithelial cells synthesize granulocyte-macrophage colony-stimulating factor and interleukin-6 in pregnant and non-pregnant mice
20. Immunohistochemical localization of granulocytemacrophage colony-stimulating factor in matched endometriosis and endometrial tissues
21. Epithelial cells are the major source of biologically active granulocyte macrophage colony-stimulating factor in human endometrium
22. The expression of granulocyte macrophage-colony stimulating factor (GM-CSF) and receptors in human endometrium
23. Role of high molecular weight seminal vesicle proteins in eliciting the uterine inflammatory response to semen in mice
24. Seminal transforming growth factor β1 stimulates granulocytemacrophage colony-stimulating factor production and inflammatory cell recruitment in the murine uterus
25. Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice
26. Granulocyte macrophage-colony stimulating factor production by autologous endometrial co-culture is associated with outcome for in vitro fertilization patients with a history of multiple implantation failures
27. Molecular cloning and characterisation of a second subunit of the interleukin 1 receptor complex
28. The biology of interleukin-1
29. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice
30. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock
31. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme
32. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice
33. Reproduction in mice lacking a functional type 1 IL-1 receptor
34. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist
35. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium
36. The cytoskeleton of uterine epithelial cells: A new player in uterine receptivity and the plasma membrane transformation
37. A newly defined interleukin-1
38. Interleukin-1β, human leukocyte antigen HLA-DRa, and transforming growth factor-β expression in endometrium, placenta and placental membranes
39. Detection of IL-1 alpha and IL-1 beta gene expression by in situ hybridization. Tissue localization of IL-1 mRNA in the normal C57BL/6 mouse
40. Localization of interleukin-1 type I receptor and interleukin-1 beta in human endometrium throughout the menstrual cycle
41. Cytokine expression in human endometrium throughout the menstrual cycle
42. Interleukin-1 type I receptor messenger ribonucleic acid expression in human endometrium throughout the menstrual cycle
43. Cytokine involvement in oocytes and early embryos
44. Prediction of successful embryo implantation by measuring interleukin-1 and immunosuppressive factor(s) in preimplantation embryo culture fluid
45. Determination of IL-1 and IL-6 levels in human embryo culture-conditioned media
46. Detection of cytokines (interleukin-1, interleukin-6, transforming growth factor-beta) and soluble tumour necrosis factor receptors in embryo culture during in-vitro fertilization
47. Absence of immunoreactive cytokines in supernatants of individual preimplantation human embryos
48. Interleukin-1beta and interleukin-1alpha may affect the implantation rate of patients undergoing in vitro fertilization-embryo transfer
49. The interleukin-1 system and human implantation
50. Soluble cytokine receptors
51. Identification of a second murine interleukin-11 receptor alpha chain gene (IL11Ra2) with a restricted pattern of expression
52. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation
53. Expression of interleuken-11 during the human menstrual cycle: Coincidence with stromal cell decidualization and relationship to leukaemia inhibitory factor and prolactin
54. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window
55. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation
56. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos
57. Expression of leukaemia inhibitory factor receptor subunits LIFR beta and gp130 in human oocytes and preimplantation embryos
58. Purification of a factor inducing differentiation of mouse myeloid leukaemic M1 cells from conditional medium of mouse fibroblast L929 cells
59. Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukaemia cell lines
60. Purification of a murine leukaemia inhibitory factor from Krebs ascites conditioned cells
61. LIF lots of interesting functions
62. Leukemia inhibitory factor: A puzzling polyfunctional regulator
63. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides
64. Myeloid leukaemia inhibitory factor maintains the developmental potential for embryonic stem cells
65. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor
66. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation
67. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro
68. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation
69. Leukaemia inhibitory factor and the regulation of pre-implantation development of the mammalian embryo
70. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death
71. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and haematological disorders
72. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo
73. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
74. Expression of leukemia inhibitory factor in human endometrium and placenta
75. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium
76. Leukemia inhibitory factor in human endometrium throughout the menstrual cycle
77. Prostaglandins and menstruation
78. The effects of various doses of mifepristone on endometrial leukaemia inhibitory factor in the midluteal phase: An immunohistochemical study
79. The production of leukaemia inhibitory factor by human endometrium: Presence in uterine flushings and production by cells in culture
80. Mitogenic actions of endothelin and other growth factors in ovine endometrium
81. Leukaemia inhibitory factor gene mutates in infertile women
82. In vivo endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant culture from fertile and infertile women
83. Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation
84. Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium
85. Interleukin-11: A multifactorial growth factor derived from the hematopoietic microenvironment
86. Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease
87. Maternal IL-11R function is required for normal decidua and fetoplacental development in mice
88. Sequential appearance of relaxin, prolactin and IGFBP-1 during growth and differentiation of the human endometrium
89. Hematopoietic, immunomodulatory and epithelial effects of interleukin-11
90. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon?
91. Impaired immune and acute-phase responses in interleukin-6-deficient mice
92. The effect of interleukin-6 deficiency on implantation, fetal development and parturition in mice
93. The TGF-β superfamily: New members, new receptors and new genetic tests of function in different organisms
94. Specificity, diversity, and regulation in TGF-beta superfamily signaling
95. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis
96. Cellular and extracellular biology of the latent transforming growth factor-β binding proteins
97. TGF-β: A critical modulator of immune cell function
98. Cell type-specific expression of transforming growth factor-beta 1 in the mouse uterus during the periimplantation period
99. Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: Analysis of the periimplantation period and effects of ovarian steroids
100. Transforming growth factors beta 1, beta 2, and beta 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: A comparison to other estrogen-regulated genes
101. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: Evidence for paracrine and autocrine action
102. Temporal and site-specific expression of transforming growth factor-beta4 in human endometrium
103. Transforming growth factor beta1 in the human endometrium: Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1
104. 1 knockout mice: A mutation in one cytokine gene causes a dramatic inflammatory disease
105. Targeted disruption of the mouse transforming growth factor-beta 1 gene in multifocal inflammatory disease
106. Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice
107. Maternal rescue of transforming growth factor-β 1 null mice
108. Pituitary FSH is released by a heterodimer of the beta-subunits from the three forms of inhibin
109. Chemical and biological characterization of the inhibin family of protein hormones
110. Paracrine regulation of reproductive function by inhibin and activin
111. Roles of inhibins, activins, and follistatin in the female reproductive system
112. Inhibins and activins in human ovulation, conception and pregnancy
113. An update on the role of inhibin, activin, and follistatin as local regulators of folliculogenesis
114. Regulation of cellular and system function by activin
115. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception
116. Human decidual stromal cells express α-smooth muscle actin and show ultrastructural similarities with myofibroblasts
117. Stimulation of activin receptor II signalling pathways inhibits differentiation of multiple gastric epithelial lineages
118. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions
119. 2-macroglobulin and follistatin
120. Expression of activins and TGF beta 1 and beta 2 RNAs in early postimplantation mouse embryos and uterine decidua
121. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development
122. Fetal undernutrition and disease in later life